Daniel Lee Flynn Deciphera Pharmaceuticals, Inc. (DCPH) insider trading activity

DCPH Quotes by TradingView

Daniel Lee Flynn is Chief Scientific Officer of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 57,158 shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Jun 16, 2023, when has been sold 1,655 shares (Common Stock) at a price of $14.4 per share, resulting in proceeds of $23,832. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.2K
0% 3M change
0% 12M change
Total Value Held $0

Daniel Lee Flynn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2023
SELL
Open market or private sale
$23,832 $14.4 p/Share
1,655 Reduced 2.81%
57,158 Common Stock
Feb 16 2023
SELL
Open market or private sale
$20,687 $15.1 p/Share
1,370 Reduced 2.28%
58,813 Common Stock
Feb 15 2023
BUY
Grant, award, or other acquisition
-
16,488 Added 21.5%
60,183 Common Stock
Jan 17 2023
SELL
Open market or private sale
$51,039 $21.24 p/Share
2,403 Reduced 5.21%
43,695 Common Stock
Jun 16 2022
SELL
Open market or private sale
$19,006 $10.75 p/Share
1,768 Reduced 3.69%
46,098 Common Stock
Feb 16 2022
SELL
Open market or private sale
$12,362 $9.05 p/Share
1,366 Reduced 2.77%
47,866 Common Stock
Jan 18 2022
BUY
Grant, award, or other acquisition
-
20,500 Added 29.4%
49,232 Common Stock
Dec 15 2021
BUY
Grant, award, or other acquisition
-
11,100 Added 27.87%
28,732 Common Stock
Feb 16 2021
SELL
Open market or private sale
$24,826 $48.87 p/Share
508 Reduced 7.22%
6,532 Common Stock
Feb 16 2021
BUY
Grant, award, or other acquisition
-
11,100 Added 38.63%
17,632 Common Stock
DLF

Daniel Lee Flynn

Chief Scientific Officer
Waltham, MA

Track Institutional and Insider Activities on DCPH

Follow Deciphera Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DCPH